Atlas Trials

Bioequivalence Study of 2 Sizes of SHR4640 Tablets Orally in Healthy Subjects

Clinical trial NCT06168929 · COMPLETED

Trial details

NCT number
NCT06168929
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hyperuricemia
Start date
2023-12-13
Primary completion
2024-01-13
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.